Version 4.0.201701

Home - Cell Index - Search - Web Sites
Species - Tissues - Tumors - Pathologies - Tr. Agents
Collections - Laboratories - Catalogues

For information, get in touch with: Dott.ssa Assunta Manniello
Email: mariaassunta.manniello@hsanmartino.it
  P. Romano, A. Manniello et al. Nucl Acids Res 2009 37:D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105

Short description of cell lines.
Species: rat (all strains)


- By clicking on the cell line name, you will retrieve the detailed description of the cell line
- By clicking on one of the terms between parentheses, you will retrieve the list of all rilevant cell line

208F (fibroblast) - ECACC
2211 (glioma) - SPBIC
33B (neural, oligodendroglioma) - ECACC
35 (glioma) - SPBIC
4/4 RM-4 (pleura, visceral, mesothelium) - ECACC
424 MPSV ts (thyroid) - NAUBP
424 MPSV wt (thyroid) - NAUBP
58967 NRK (kidney) - NAUBP
6-23 (clone 6) (thyroid, medullary, carcinoma) - ECACC
6-23 (clone 6) (thyroid, medullary, carcinoma) - IZSBS
663 + N (kidney) - NAUBP
A-10 (muscle,smooth) - DSMZ
A-S-30D (liver, hepatoma) - DSMZ
A10-85 (brain, glioma) - ECACC
A15 (glioma) - ECACC
A7r5 (aorta thoracic, embryonic) - ECACC
A7r5 (aorta thoracic, embryonic) - PNIOS
AF-1 (MHV) (kidney) - NAUBP
Anr4 (liver) - ECACC
AR42J (pancreas, pancreatic tumor) - ECACC
AR42J (pancreas, pancreatic tumor) - VRUCB
AR4IP (pancreas, pancreatic tumor) - VRUCB
ARL-6 (liver, hepatoma) - ECACC
ARLJ 301-3 (liver) - ECACC
AT-1 (prostate, adenocarcinoma) - ECACC
AT-3.1 (prostate, adenocarcinoma) - ECACC
AT6.1 (prostate, adenocarcinoma) - ECACC
B104 (brain, neuroblastoma) - ICLC
B12 (nervous system, tumor) - ECACC
B50 (nervous system, nervous tissue glial tumor) - ECACC
B50 (nervous system, nervous tissue glial tumor) - IZSBS
B65 (nervous system, nervous tissue neuronal tumor) - ECACC
B92 (nervous system, nervous tissue glial tumor) - ECACC
BE10-7 (brain, premalignant) - ECACC
BE10-Intermediate (brain, fetal, premalignant) - ECACC
BE10-Late (fetal brain, brain malignant) - ECACC
BE11 (Early) (brain, fetal) - ECACC
BPE (lung, embryonic) - GEICH
BRL 3A (liver) - ECACC
BRL 3A (liver) - NAUBC
BRL-1 (liver) - ECACC
BRL-3A (liver) - ICLC
C2 (liver, hepatoma) - ECACC
C2-Rev 7 (liver, hepatoma) - ECACC
C2-Rev7 (hepatoma) - ICLC
C6 (neural, glial tumor) - ECACC
C6 (neural, glial tumor) - ECACC
C6 (glial tumor) - ICLC
C6 (glial tumor) - IZSBS
C6 (glial tumor) - SPBIC
C6-BU-1 (brain, tumor) - DSMZ
CC-1 (liver) - ECACC
CEINGE CLONE 3 (brain) - ICLC
CEINGE CLONE 3 (brain, embryonic) - NAUBC
Clone 9 (liver) - ECACC
Clone D (mammary gland, carcinoma) - TOUCI
Clone H (mammary gland, carcinoma) - TOUCI
Clone I (mammary gland, carcinoma) - TOUCI
Clone L (mammary gland, carcinoma) - TOUCI
CRI-10P (islet tumor) - ECACC
CRI-D11 (pancreas, islet tumor) - ECACC
CRI-D11 (insulinoma) - IZSBS
CRI-D2 (islet tumor) - ECACC
CRI-G1 (pancreas, islet tumor) - ECACC
CRI-G5 (pancreas, islet tumor) - ECACC
DFK3 (embryo) - SPBIC
DHD/K12/TRb (colon, carcinoma) - ECACC
EL 2 (embryo) - VRUCB
EPI (mammary gland, carcinoma) - TOUCI
F11 (dorsal root ganglion) - MIUFG
Fao (liver, hepatoma) - ECACC
FAO (liver, hepatoma, H-35 Reuber) - ICLC
FG/223 (skin, fibroblast) - SSUFG
FG/25 (skin, fibroblast) - SSUFG
FG/4 (skin, fibroblast) - SSUFG
FG/45 (skin, fibroblast) - SSUFG
FG/90 (skin, fibroblast) - SSUFG
FGC4 (skin, hepatoma) - ECACC
FR (skin) - ECACC
FRT (thyroid) - NAUBP
FRT-Fibro KiMSV (thyroid) - NAUBP
FRT-L KiKi (thyroid) - NAUBP
FRT-L KiMol wt (thyroid) - NAUBP
FRT-L KiMolts (thyroid) - NAUBP
FRT-U10 (thyroid) - NAUBC
FRTL-5 (thyroid) - NAUBP
G (prostate, adenocarcinoma) - ECACC
GH 1 (pituitary tumor) - IZSBS
GH 3 (pituitary tumor) - IZSBS
GH1 (pituitary, pituitary tumor) - ECACC
GH3 (pituitary, pituitary tumor) - ECACC
GH3 (pituitary tumor) - ICLC
GH3 (pituitary tumor) - SPBIC
GH4-C1 (pituitary adenoma) - ICLC
GS-9L (neural, glioma) - ECACC
GS-9L (glioma) - ICLC
H-4-II-E (liver, hepatoma) - ECACC
H-4-II-E (liver, hepatoma) - IZSBS
H4-II-E-C3 (liver, hepatoma) - ECACC
H4-II-E-C3 (liver, hepatoma) - GEUCC
H4-II-E-C3 (liver, hepatoma) - IZSBS
H4-II-E-C3 (liver, hepatoma) - PGUPG
H4II (skin, carcinoma, hepatocellular) - ECACC
H4S (liver, hepatoma) - ECACC
H4TG (liver, hepatoma) - IZSBS
H5 (liver, hepatoma) - ECACC
H9c2 (2-1) (heart) - ECACC
H9c2(2-1) (heart) - IZSBS
HF1 (liver, hepatoma) - ECACC
HF1-5 (liver, hepatoma) - ECACC
HTC (liver, hepatoma) - ECACC
HTC (ascitic fluid, hepatoma) - GEUCC
HTC (ascitic fluid, hepatoma) - ICLC
HTC (ascitic fluid, hepatoma) - SPBIC
HTC (BUdR) (liver, hepatoma) - ECACC
IA-Xs SBR (intestine, small, adenocarcinoma) - ECACC
IEC 18 (intestine, ileum) - ECACC
IEC 6 (intestine, small) - ECACC
IEC-6 (intestine, small) - DSMZ
IEC-6 (intestine, small) - IZSBS
Jensen sarcoma (sarcoma) - ECACC
Jensen sarcoma (sarcoma) - IZSBS
JF1 (sarcoma, Jensen) - SPBIC
JM2 (liver, hepatoma) - ICLC
JTC-19 (lung, embryonic) - ECACC
JTC-27 (ascitic fluid, hepatoma) - ECACC
JTC-27 (liver, hepatoma) - ICLC
K22 (fibroblast) - SPBIC
K29 (fibroblast) - SPBIC
KNRK (kidney) - ECACC
L-2 (lung) - ECACC
L6 (skeletal muscle) - IZSBS
L6 (muscle) - SPBIC
L6.C10 (skeletal muscle) - ECACC
L6.C11 (skeletal muscle) - ECACC
L6.G8 (skeletal muscle) - ECACC
L6.G8.C5 (skeletal muscle) - ECACC
L6C5 (skeletal muscle) - ICLC
L6H2 - ICLC
L6J1 (muscle) - SPBIC
L8 (muscle) - SPBIC
LA7 (mammary gland, carcinoma) - ECACC
LC 540 (testis, Leydig cells, testicular tumor) - IZSBS
LC540 (testis, Leydig cells, testicular tumor) - ECACC
LF-CL2A (liver, carcinoma, hepatocellular) - DSMZ
LLC-WRC 256 (carcinoma) - ECACC
LLC-WRC 256 (carcinoma) - IZSBS
MAT-Lu (prostate, adenocarcinoma) - ECACC
MAT-LyLu (prostate, adenocarcinoma) - ECACC
MCA-RH 7777 (liver, hepatoma) - ECACC
McA-RH7777 (liver, hepatoma) - GEUCC
McA-RH7777 (liver, hepatoma) - ICLC
McA-RH7777 (liver, hepatoma) - MWIIW
MH 1 C 1 (liver, hepatoma) - IZSBS
MH1C1 (liver, hepatoma) - DSMZ
MH1C1 (liver, hepatoma) - ECACC
MH1C1 (liver, hepatoma) - GEUCC
MH1C1 (liver, hepatoma) - ICLC
N1-S1 (liver, hepatoma) - ECACC
Nb2-11 (thymus, lymphoma) - ECACC
NBT-II (bladder, cancer) - ECACC
NGUK-1 (Gasser's node, neurinoma) - MWIIW
NRK (kidney, fibroblast) - ECACC
NRK (kidney, fibroblast) - MWIIW
NRK 49F (kidney) - IZSBS
NRK-49F (kidney) - CHIBC
NRK-49F (kidney, fibroblast) - DSMZ
NRK-49F (kidney) - ECACC
NRK-49F (kidney) - MIISB
NRK-49F (kidney) - SPBIC
NRK-52E (kidney) - DSMZ
NRK-52E (kidney) - ECACC
PC-12 (adrenal, pheochromocytoma) - DSMZ
PC-12 (adrenal medulla, pheochromocytoma) - ECACC
PC-12 (adrenal, pheochromocytoma) - ICLC
PC-12 (adrenal medulla, pheochromocytoma) - IZSBS
PC-12 (adrenal medulla, pheochromocytoma) - PGUPG
Phi 1 (liver, hepatoma) - ECACC
PQ (aorta, thoracic) - MIUFC
R 2 C (testis, Leydig cells, testicular tumor) - IZSBS
R2C (testis, Leydig cells, testicular tumor) - ECACC
R74 (fibroblast, embryonic) - ECACC
R9 (fibroblast, embryonic) - ECACC
Rasheed Sarcoma Virus (kidney) - NAUBP
RASMC (aorta) - MIECC
RAT-2 (embryo) - ECACC
Rat2 (embryo) - MIISA
Rat2 (embryo) - SPBIC
RBL 1 (leukemia, basophilic) - IZSBS
RBL-1 (leukemia, basophilic) - DSMZ
RBL-1 (leukemia, basophilic) - ECACC
RBL-1 (peripheral blood, leukemia, basophilic) - ICLC
RBL-1 (leukemia, basophilic) - SPBIC
RC-4B/C1 (adenoma) - ECACC
RENE 1 (endometrium) - ECACC
RENE 2 (endometrium) - ECACC
RENT 4 (endometrium) - ECACC
RENT RO1 (endometrium) - ECACC
RENT RO3 (endometrium) - ECACC
RENT ts3.1 (endometrium) - ECACC
RENT tsS1.1 (endometrium) - ECACC
RFL 6 (lung) - IZSBS
RFL-6 (lung) - ECACC
RGE (glomerulal, endothelial cells) - DSMZ
RIN-5F (islet tumor) - ECACC
RIN-m (islet tumor) - ECACC
RLC (lymphosarcoma) - SPBIC
RLC 27 (liver) - ECACC
RN 22 - ECACC
RR 1022 (sarcoma) - IZSBS
RR1022 (sarcoma) - ECACC
RRAm1 (skin, fibroblast) - ICLC
RT 1 (fibrosarcoma) - ECACC
RT-1 (fibrosarcoma) - ICLC
RT4-D6P2T (nervous system, not defined tumor) - ECACC
SGS (sarcoma) - SSUFG
SGS/3A (sarcoma) - SSUFG
SMC-1 (aorta) - MOECC
SMC-BN1 (aorta, thoracic) - CHIBC
SMC-BN2 (aorta, thoracic) - CHIBC
SMC-RG (aorta, thoracic) - CHIBC
SMC-RV (aorta, thoracic) - CHIBC
SMC-YOS1 (aorta, thoracic) - CHIBC
SMC-YOS2 (aorta, thoracic) - CHIBC
TE (lung, embryonic) - GEICH
TR33B (spinal cord and roots, oligodendroglioma) - ECACC
TWERC (embryo) - MWIIW
UMR-106 (sarcoma, osteogenic) - ECACC
UMR-108 (sarcoma, osteogenic) - ECACC
WB2054M (colon, carcinoma) - ECACC
WRC (carcinoma) - ECACC
XC (sarcoma) - DSMZ
XC (sarcoma) - ECACC
XC (sarcoma) - ICLC
XC (sarcoma) - IZSBS
XC (sarcoma) - MWIIW
XCp (sarcoma) - SPBIC
Y3.Ag.1.2.3 (myeloma) - ANIIR
Y3.AG.1.2.3 (myeloma) - ECACC
YO (myeloma) - ECACC


For information, get in touch with:
IRCCS AOU San Martino IST,
c/o Centro Biotecnologie Avanzate, Torre D - Piano 2

Largo Rosanna Benzi, 10 - I-16132 Genova - Italy
Dott.ssa Assunta Manniello
Email: mariaassunta.manniello@hsanmartino.it

If you want to cite CLDB and HyperCLDB, please use the following reference:

P. Romano, A. Manniello, O. Aresu, M. Armento, M. Cesaro, B. Parodi.
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.
Nucleic Acids Research 2009 37(Database issue):D925-D932.
DOI: doi:10.1093/nar/gkn730; PMID: 18927105